COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 17 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,253,628 | -30.6% | 577,909 | 0.0% | 6.54% | -29.0% |
| Q2 2023 | $4,686,842 | +15.5% | 577,909 | 0.0% | 9.21% | +0.3% |
| Q1 2023 | $4,056,921 | -19.8% | 577,909 | -4.5% | 9.19% | -26.6% |
| Q4 2022 | $5,055,399 | +22.1% | 605,437 | 0.0% | 12.52% | +39.6% |
| Q3 2022 | $4,141,000 | -16.0% | 605,437 | 0.0% | 8.96% | -6.6% |
| Q2 2022 | $4,928,000 | -27.9% | 605,437 | +1.3% | 9.60% | -13.1% |
| Q1 2022 | $6,837,000 | -15.7% | 597,662 | +20.6% | 11.05% | +2.2% |
| Q4 2021 | $8,109,000 | -14.7% | 495,684 | -12.0% | 10.81% | -14.1% |
| Q3 2021 | $9,504,000 | -20.4% | 563,030 | 0.0% | 12.59% | -9.8% |
| Q2 2021 | $11,942,000 | – | 563,030 | – | 13.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 577,909 | $4,686,842 | 9.21% |
| VILLERE ST DENIS J & CO LLC | 292,723 | $2,388,619 | 0.17% |
| PINNACLE ASSOCIATES LTD | 484,653 | $3,954,768 | 0.07% |
| FNY Investment Advisers, LLC | 1,539 | $12 | 0.02% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 49,210 | $399 | 0.02% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 23,171 | $187,917 | 0.00% |
| BROWN ADVISORY INC | 73,849 | $602,608 | 0.00% |
| Geneos Wealth Management Inc. | 750 | $6,083 | 0.00% |
| Focused Wealth Management, Inc | 242 | $1,975 | 0.00% |
| UBS Group AG | 6,548 | $53,432 | 0.00% |